Get started
PHILOGEN

phil

By LUCA.P
rispoetto alle discese die mercati il titolo si difende bene con una possibile fase distributiva in attesa dell'approvazione dall' fda
Trend Analysis
LUCA.P
Luca Proietti.


WWW.OROSAM.IT
Also on:

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.